Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02725684 · ClinicalTrials.gov registry record
Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 36
- Enrollment target
NCT02725684: Completed study, sponsored by Rockefeller University.
NCT02725684 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02725684 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the use of genomics can help identify patient specific treatment choices in cancer. In order to test this, the investigators plan to use genomic sequencing technology to identify patient specific mutations in glioblastoma multiforme (GBM) as compared to normal cells to identify mutations. Further analysis will identify potential treatment targets and whether there are any drugs that could be used for these particular mutations. Follow up clinical data will be assessed to see if this individualized method of choosing treatment options can improve clinical outcomes in patients with GBM.
Primary Outcome
Identification of variants in each tumor that are potential drug targets
Interventions
- OTHER Observational study, no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2015-03-12 |
| Est. Completion | 2017-07-07 |
What the finished NCT02725684 record still lists
NCT02725684 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observational study, no intervention is the first listed.
NCT02725684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02725684 about?
NCT02725684 is a clinical study titled "Using Genomic Analysis to Guide Individual Treatment in Glioblastoma". The purpose of this study is to assess whether the use of genomics can help identify patient specific treatment choices in cancer. In order to test this, the investigators plan to use genomic sequencing technology to identify patient specific mutations in glioblastoma multiforme (GBM) as compared to...
What is the current status of trial NCT02725684?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2015-03-12. Estimated completion is 2017-07-07.
What interventions are being tested in trial NCT02725684?
The interventions under investigation include: Observational study, no intervention (OTHER).
Who is sponsoring clinical trial NCT02725684?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI